Cargando…

The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma

Chemotherapeutic treatments against hepatocellular carcinoma (HCC) are necessary for both inoperable patients to improve prospects for survival and surgery patients to improve the outcome after surgical resection. However, multidrug resistance (MDR) is a major obstacle to obtaining desirable results...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yang, Chen, Jing, Wei, Wenxin, Qi, Xinming, Li, Chunzhu, Ren, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837112/ https://www.ncbi.nlm.nih.gov/pubmed/29527329 http://dx.doi.org/10.1038/s41392-017-0003-4

Ejemplares similares

Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2015)

miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
por: Chen, Jing-Song, et al.
Publicado: (2016)

Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR‐338‐3p‐PKLR axis in hepatocellular carcinoma
por: Nie, Huizhen, et al.
Publicado: (2015)

circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression
por: Liu, Guangming, et al.
Publicado: (2020)

miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2
por: Wen, Chunyan, et al.
Publicado: (2021)

Molecular interactions of miR-338 during tumor progression and metastasis
por: Moghbeli, Meysam
Publicado: (2021)

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis
por: Liang, Yingchun, et al.
Publicado: (2017)

MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation
por: Howe, James R., et al.
Publicado: (2017)

MiR-338-3p improved lung adenocarcinoma by AKAP12 suppression
por: Chang, Jin, et al.
Publicado: (2019)

miR-338-3p inhibits the invasion of renal cell carcinoma by downregulation of ALK5
por: Zhang, Xiaoqian, et al.
Publicado: (2017)

Effects of miR-219/miR-338 on microglia and astrocyte behaviors and astrocyte-oligodendrocyte precursor cell interactions
por: Nguyen, Lan Huong, et al.
Publicado: (2019)

Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data
por: Liang, Liang, et al.
Publicado: (2018)

Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p
por: Xing, Zhiwei, et al.
Publicado: (2016)

Circular RNA SMO sponges miR-338-3p to promote the growth of glioma by enhancing the expression of SMO
por: Xiong, Zhiyong, et al.
Publicado: (2019)

MECP2 promotes the growth of gastric cancer cells by suppressing miR-338-mediated antiproliferative effect
por: Tong, Dongdong, et al.
Publicado: (2016)

Inhibitory effect of miR-140-5p on doxorubicin resistance of hepatocellular carcinoma
por: Gao, Xiaojie, et al.
Publicado: (2021)

miR-338-3p inhibits cell growth, invasion, and EMT process in neuroblastoma through targeting MMP-2
por: Yuan, Haibin, et al.
Publicado: (2021)

Relationship between miR-338-3p and Clinicopathological Parameters, Prognosis, and STAT3 mRNA Expression in Nasopharyngeal Carcinoma
por: Wang, Youyou, et al.
Publicado: (2021)

Hsa_circ_0008945 promoted breast cancer progression by targeting miR-338-3p
por: Zhang, Li, et al.
Publicado: (2019)

miR-338-3p suppresses the malignancy of T-cell lymphoblastic lymphoma by downregulating HOXA3
por: Wang, Li, et al.
Publicado: (2019)

Serum miR-338-5p has potential for use as a tumor marker for retinoblastoma
por: Zhou, Peng, et al.
Publicado: (2019)

Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer
por: Yong, Fung Lin, et al.
Publicado: (2013)

miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
por: Gao, Man, et al.
Publicado: (2016)

Expression and role of miR-338-3p in peripheral blood and placenta of patients with pregnancy-induced hypertension
por: Li, Jun, et al.
Publicado: (2020)

IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p
por: Zhang, Yunhong, et al.
Publicado: (2020)

Disregulations of PURPL and MiR-338-3p Could Serve As Prognosis Biomarkers for Epithelial Ovarian Cancer
por: Zhang, Ruitao, et al.
Publicado: (2021)

69742 miR-338-5p as a Biomarker of Neuropathic Pain After Spinal Cord Injury
por: Kowalski, Jesse, et al.
Publicado: (2021)

KLF9 regulates miR-338-3p/NRCAM axis to block the progression of osteosarcoma cells
por: Liu, Yunlu, et al.
Publicado: (2022)

Hsa_circ_0008945 Promoted Breast Cancer Progression by Targeting miR-338-3p [Retraction]
Publicado: (2023)

MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin
por: Park, Misun, et al.
Publicado: (2017)

Sequential expression of miR-221-3p and miR-338-3p in Schwann cells as a therapeutic strategy to promote nerve regeneration and functional recovery
por: Wen, Li-Li, et al.
Publicado: (2022)

Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration
por: Yin, Liqian, et al.
Publicado: (2023)

MiR‐139‐5p, miR‐940 and miR‐193a‐5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1
por: Li, Peng, et al.
Publicado: (2019)

Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP
por: Li, Pu, et al.
Publicado: (2013)

miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B
por: Sun, Feng, et al.
Publicado: (2018)

LncRNA‐SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR‐338‐3p
por: Li, Min, et al.
Publicado: (2019)

Hypoxia‐inhibited miR‐338‐3p suppresses breast cancer progression by directly targeting ZEB2
por: He, Juanjuan, et al.
Publicado: (2020)

MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B
por: Niu, Qin, et al.
Publicado: (2019)

miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer
por: Wei, Xiaoli, et al.
Publicado: (2021)

circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury
por: Zhu, Jiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6bc55lh4rp5mepnj743ug9dmt